Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT00446069
Eligibility Criteria:
Inclusion Criteria:
* The patient has stable strong opioid use equipotent to 30-240 mg oral morphine sulphate daily for a minimum of 2 weeks prior to entering the run-in phase.
* The patient has opioid-sensitive pain caused by active cancer.
* The patient is aged minimum 18 years.
Exclusion Criteria:
* The patient has a life expectancy less than 2 months.
* The patient has received chemotherapy or radiation therapy less than 4 weeks prior to entering run-in phase
* Patients with medical conditions contraindicating morphine treatment
* The patient has hepatic disease or impaired kidney function
* The patient is taking monoamine oxidase inhibitors (MAOIs) or has taken a MAOI within two weeks prior to entering baseline.
* The patient is taking other opioid agonists or antagonists, zidovudine or cimetidine.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00446069
Study Brief:
Protocol Section:
NCT00446069